Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Structural evolution of toll-like receptor 7/8 agonists from imidazoquinolines to imidazoles
Deepender Kaushik, Arshpreet Kaur, Nikolai Petrovsky, et al.
RSC Medicinal Chemistry (2021) Vol. 12, Iss. 7, pp. 1065-1120
Open Access | Times Cited: 28

Showing 1-25 of 28 citing articles:

Toll-like receptor (TLR) agonists as a driving force behind next-generation vaccine adjuvants and cancer therapeutics
Arshpreet Kaur, Jeremy Baldwin, Deshkanwar Brar, et al.
Current Opinion in Chemical Biology (2022) Vol. 70, pp. 102172-102172
Open Access | Times Cited: 96
Tumor‐Associated Macrophages Nano‐Reprogrammers Induce “Gear Effect” to Empower Glioblastoma Immunotherapy
Yang Wang, Guangzhe Li, Jianlong Su, et al.
Small (2025)
Closed Access | Times Cited: 1
Toll-like receptors and toll-like receptor-targeted immunotherapy against glioma
Yang Xun, Hua Yang, Bożena Kamińska, et al.
Journal of Hematology & Oncology (2021) Vol. 14, Iss. 1
Open Access | Times Cited: 84
Toll-like receptor agonists as cancer vaccine adjuvants
Donghwan Jeon, Ethan C. Hill, Douglas G. McNeel
Human Vaccines & Immunotherapeutics (2023) Vol. 20, Iss. 1
Open Access | Times Cited: 15
Structure-activity relationship in NOD2 agonistic muramyl dipeptides
Aarzoo Kamboj, Madhuri T. Patil, Nikolai Petrovsky, et al.
European Journal of Medicinal Chemistry (2024) Vol. 271, pp. 116439-116439
Closed Access | Times Cited: 5
Proficiency of Pluronic Based Niosomes as an Effective Nano-carrier for the Formulation of Toll-Like Receptor-7/8 Agonists
Jyoti Rathee, Kushvinder Kumar, Aishwarya Keluskar, et al.
Journal of Drug Delivery Science and Technology (2025), pp. 106764-106764
Closed Access
Role of toll-like receptor 7/8 pathways in regulation of interferon response and inflammatory mediators during SARS-CoV2 infection and potential therapeutic options
Shetty Ravi Dyavar, Rahul Singh, Rohini Emani, et al.
Biomedicine & Pharmacotherapy (2021) Vol. 141, pp. 111794-111794
Open Access | Times Cited: 37
Structure–Activity Relationships toward the Identification of a High-Potency Selective Human Toll-like Receptor-7 Agonist
Deepender Kaushik, Arshpreet Kaur, Madhuri T. Patil, et al.
Journal of Medicinal Chemistry (2024) Vol. 67, Iss. 10, pp. 8346-8360
Closed Access | Times Cited: 4
Design and Synthesis of Polyphenolic Imidazo[4,5-c]quinoline Derivatives to Modulate Toll Like Receptor-7 Agonistic Activity and Adjuvanticity
Kushvinder Kumar, Binita Sihag, Madhuri T. Patil, et al.
ACS Pharmacology & Translational Science (2024) Vol. 7, Iss. 7, pp. 2063-2079
Closed Access | Times Cited: 4
Small molecule modulators of immune pattern recognition receptors
Taku Tsukidate, Charles W. Hespen, Howard C. Hang
RSC Chemical Biology (2023) Vol. 4, Iss. 12, pp. 1014-1036
Open Access | Times Cited: 11
Identification and Optimization of Small Molecule Pyrazolopyrimidine TLR7 Agonists for Applications in Immuno-oncology
Liqi He, Meng Yao Zhang, Matthew Cox, et al.
ACS Medicinal Chemistry Letters (2024) Vol. 15, Iss. 2, pp. 189-196
Closed Access | Times Cited: 3
Molecule engineering strategy of toll-like receptor 7/8 agonists designed for potentiating immune stimuli activation
Liuwei Gu, Xiaojie Kong, Mengyan Li, et al.
Chemical Communications (2024) Vol. 60, Iss. 42, pp. 5474-5485
Closed Access | Times Cited: 2
Modulation of the Adjuvant Potential of Imidazoquinoline-Based TLR7/8 Agonists via Alum Adsorption
Kushvinder Kumar, Yoshikazu Honda‐Okubo, Isaac G. Sakala, et al.
ACS Medicinal Chemistry Letters (2024) Vol. 15, Iss. 10, pp. 1677-1684
Closed Access | Times Cited: 2
Structure−Activity Relationships Towards the Identification of High-Potency Selective Human Toll-Like Receptor-7 Agonist
Deepender Kaushik, Arshpreet Kaur, Madhuri Patil, et al.
(2024)
Open Access | Times Cited: 1
Interleukin‐1 receptor‐associated kinase 4 (IRAK4) is a critical regulator of inflammatory signalling through toll‐like receptors 4 and 7/8 in murine and human lungs
Ian Sayers, Dhruma Thakker, Charlotte K. Billington, et al.
British Journal of Pharmacology (2024) Vol. 181, Iss. 22, pp. 4647-4657
Open Access | Times Cited: 1
Unveiling the multifaceted role of toll-like receptors in immunity of aquatic animals: pioneering strategies for disease management
Muhammad Usman Ghani, Junfan Chen, Zahra Khosravi, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 1
Toll-like receptor 7 and 8 imidazoquinoline-based agonist/antagonist pairs
Mu Yang, Peter Larson, Lincoln Brown, et al.
Bioorganic & Medicinal Chemistry Letters (2022) Vol. 59, pp. 128548-128548
Closed Access | Times Cited: 8
Lignin nanoparticles as a novel carrier for efficacious delivery of toll like receptor 7/8 agonist: Physicochemical and in-vitro evaluation
Sangeeta Sharma, Arshpreet Kaur, Sunil Kumar, et al.
Journal of the Indian Chemical Society (2023) Vol. 100, Iss. 5, pp. 101008-101008
Closed Access | Times Cited: 4
Combined delivery of TLR2 and TLR7 agonists by Nanostructured lipid carriers induces potent vaccine adjuvant activity in mice
Arshpreet Kaur, Rohini Kanwar, Deepender Kaushik, et al.
International Journal of Pharmaceutics (2021) Vol. 613, pp. 121378-121378
Closed Access | Times Cited: 11
Design and synthesis of novel quinazolinone derivatives as anti-HBV agents with TLR8 agonist effect
Jingying Qiu, Qingqing Zhou, Yueting Zou, et al.
European Journal of Medicinal Chemistry (2022) Vol. 231, pp. 114159-114159
Closed Access | Times Cited: 7
NAD(P)H: quinone oxidoreductase 1 activatable toll-like receptor 7/8 agonist designed for precise immunotherapy
Guo Li, Yongxiao Xu, Xiaojie Kong, et al.
Chemical Communications (2023) Vol. 59, Iss. 42, pp. 6343-6346
Closed Access | Times Cited: 3
Potential biocide roles of violacein
Ignacio Rivero Berti, Melisa E. Gantner, Santiago Rodrı́guez, et al.
Frontiers in Nanotechnology (2023) Vol. 5
Open Access | Times Cited: 3
Call for Papers: Medicinal Chemistry of Next Generation Vaccine Adjuvants
Deepak B. Salunke, Craig W. Lindsley
Journal of Medicinal Chemistry (2023) Vol. 66, Iss. 15, pp. 10119-10121
Open Access | Times Cited: 3
Ionic copolymer-modified hexagonal carbon nitride tube as a high-performance catalyst for regioselective synthesis of hexahydroquinoline frameworks
Sara Shafaati, Javad Safaei‐Ghomi, Zahra Elyasi
Colloids and Surfaces A Physicochemical and Engineering Aspects (2024) Vol. 699, pp. 134589-134589
Closed Access
Exploration of Solid Phase Peptoid Synthesis for the Design of Trifunctional Hapten-Lipid-TLR7/8 Agonist Antibody-Recruiting Oligomers That Combine Innate Effector with Innate Activation Function
Haixia Peng, Steven Martens, Annemiek Uvyn, et al.
ACS Applied Bio Materials (2024)
Closed Access
Page 1 - Next Page

Scroll to top